Laigo Bio Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$19.8M
- Investors
-
11
Laigo Bio General Information
Description
Developer of a biotechnology platform designed to develop dual-targeted therapies through protein degradation. The company's platform focuses on developing a biological approach to treat tumors and neurological diseases by targeting chimeric molecules via surface removal, enabling medical professionals to achieve sustained degradation of target receptors.
Contact Information
Website
www.laigobio.comCorporate Office
- Jaarbeursplein 6
- 3521 AL Utrecht
- Netherlands
Corporate Office
- Jaarbeursplein 6
- 3521 AL Utrecht
- Netherlands
Laigo Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Seed Round | 20-Mar-2026 | $19.8M | Completed | Generating Revenue | ||
| 2. Grant | 28-Jul-2022 | Completed | Generating Revenue | |||
| 1. Seed Round | 08-Feb-2022 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Laigo Bio Patents
Laigo Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025206956-A1 | Bispecific antigen binding proteins | Pending | 12-Jan-2024 | ||
| WO-2025149633-A1 | Bispecific antigen binding proteins | Inactive | 12-Jan-2024 |
Laigo Bio Signals
Laigo Bio Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angelini Ventures | Corporate Venture Capital | Minority | ||
| Biovance Capital Partners | Venture Capital | Minority | ||
| Cancer Research Technology | Venture Capital | Minority | ||
| Curie Capital | Venture Capital | Minority | ||
| Eurazeo | Asset Manager | Minority |
Laigo Bio FAQs
-
When was Laigo Bio founded?
Laigo Bio was founded in 2021.
-
Where is Laigo Bio headquartered?
Laigo Bio is headquartered in Utrecht, Netherlands.
-
What is the size of Laigo Bio?
Laigo Bio has 3 total employees.
-
What industry is Laigo Bio in?
Laigo Bio’s primary industry is Drug Discovery.
-
Is Laigo Bio a private or public company?
Laigo Bio is a Private company.
-
What is Laigo Bio’s current revenue?
The current revenue for Laigo Bio is .
-
How much funding has Laigo Bio raised over time?
Laigo Bio has raised $19.8M.
-
Who are Laigo Bio’s investors?
Angelini Ventures, Biovance Capital Partners, Cancer Research Technology, Curie Capital, and Eurazeo are 5 of 11 investors who have invested in Laigo Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process